 |
|
|
|
|
|
|
|
26-05-2010
In type 2 diabetes, long-term metformin treatment is linked to vitamin B12 deficiency, according to the results of a multicenter, randomized, placebo-controlled trial reported Online First May 20 in the BMJ.
»Read more...
|
3-05-2010
Irvine, CA (updated) - The clopidogrel-proton-pump inhibitor (PPI) interaction saga just keeps rumbling on, with yet another study suggesting an adverse effect of taking these two drugs together published this week.
»Read more...
|
22-04-2010
MEMS would like to congratulate society member, Assoc. Prof. Dr. Norlela Sukor from the Department of Medicine, UKM who was recently awarded the degree of Doctor of Philosophy (PhD) from the University of Queensland, Australia. The title of her thesis was "Genetic, Diagnostic and Therapeutic Aspects of Primary Aldosteronism".
»Read more...
|
31-03-2010
• In US, in certain places the life span is getting less because of obesity.
• PK2 (prokinetic) probably the most potent inhibitor of food intake.
• Daily ghrelin improves appetite in dialysis and cancer patients – experimental stage.
• MI & cancer rates halved by bariatric surgery – the only successful therapy.
• We feel full, not because of bulk in stomach or nutrients in circulation. It’s due to gut hormones.
»Read more...
|
5-03-2010
Type 2 diabetes mellitus affects approximately 24 million people in the United States, is the leading cause of kidney failure and blindness, and is associated with a doubling to quadrupling of the risk of death from cardiovascular causes. Furthermore, the prevalence of type 2 diabetes is expected to increase because of the obesity epidemic.
»Read more...
|
15-02-2010
Since the publication of the UK Prospective Diabetes Study (UKPDS) it has become widely accepted that the lower the A1c level the better is the outcome for patients with type 2 diabetes especially in terms of reducing microvascular complications. This contention is also supported by the Diabetes Control and Complications Trial (DCCT) which involved patients with type 1 diabetes. Based on the DCCT study the American Diabetes Association (ADA) set the target of 7.0 % for A1c levels while the rest of the world settle for 6.5 % instead.
»Read more...
|
|
| |
| |
26 article(s) found |
Displaying article 1 - 6 |
Page 1 of 5 |
|
| [1] 2 3 4 5 » |
| |
|
|
|
|
|
|
|
|
